Identifying potential tumor markers and antigens by database mining and rapid expression screening
about
Errors in CGAP xProfiler and cDNA DGED: the importance of library parsing and gene selection algorithmsIdentification of astrocytoma associated genes including cell surface markersProgress in the application of DNA microarraysToxin-based targeted therapy for malignant brain tumorsTP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expressionThymic model for examining BRCA2 expression and functionThe Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer.What can digital transcript profiling reveal about human cancers?MRP3: a molecular target for human glioblastoma multiforme immunotherapy.Identification of cancer/testis genes by database mining and mRNA expression analysis.An international database and integrated analysis tools for the study of cancer gene expression.Discovery of dominant and dormant genes from expression data using a novel generalization of SNR for multi-class problems.Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.The cancer genome anatomy project: online resources to reveal the molecular signatures of cancer.Chaperone proteins and brain tumors: potential targets and possible therapeutics.Dendritic cell-based immunotherapy of malignant gliomas.Lnc-CC3 increases metastasis in cervical cancer by increasing Slug expressionThe data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effectsCoexpression of neuronatin splice forms promotes medulloblastoma growth.Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).Bioinformatics for cancer immunotherapy target discovery.Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro.Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult ratsTranscriptional response to hypoxia in human tumors.Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model.Intrathecal siRNA against GPNMB attenuates nociception in a rat model of neuropathic pain.Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.Identification of COL1A1 as an invasion‑related gene in malignant astrocytoma
P2860
Q21284330-4F87151D-1450-4610-8DD3-D5EFEBBDA56BQ24795833-C6A6754A-594C-4BCB-A5E9-4B2D2D0BF80EQ24813217-864DA509-9ECD-4DD4-9649-DBA7FC2F691BQ27006226-75DE14C3-C046-45C8-B2EF-56A1F29109BAQ28510298-B3BA0EA7-A620-44C3-AD37-2C35324E2DC7Q28588910-D2AD8C55-8A91-497F-8D89-F6C039B9451BQ30724646-82EA0B54-1507-465B-8157-19D65019D54DQ30971531-F395F4CA-DF48-43F6-8BE6-175233301083Q30988770-A3522055-FF33-4B10-8C67-AF822AC14318Q31045922-B04750F2-B425-4D92-9377-E835B2FC43AAQ31087190-96CA6144-BE93-4F85-B8DA-EE0AC5FD98B8Q33374663-97D0E59B-9DDF-4A8D-B759-29B56931408EQ33687487-0ECC3A33-770E-4330-8FA2-B5CECBF2FF61Q33886564-9D0685F5-FE35-414B-86D7-671356D59607Q35008314-8EEE9441-69FE-42FF-81C7-5E0579F682EFQ35800492-21729F7F-8F41-49CB-B7AD-A7C5B37E30CFQ35922426-8F45AED7-9ECC-4454-8195-9726A4C357C9Q36028963-FF538A82-1B15-4A8C-868F-E1E9AA5E12EDQ36331372-12B87880-1B5D-4B12-A8C7-8199CC438B13Q37152032-6552247B-86A4-4F6B-BA3C-96A565D77D42Q38127467-AE174A7B-03DC-42C1-AB2B-5A2275B9D40DQ38185304-65931CE6-90D9-41B8-A683-88B6CC497A60Q38262688-582549F7-44D5-422B-BFB2-C619026D3A7AQ39056037-B06BA517-CA5E-4043-BAE8-D40E13FB6E7AQ39404086-E1987254-C06B-4CD5-B619-07060ABCA4A8Q40506981-5B6D480E-0B5E-4A47-9080-1A24EDA7C91EQ42002720-81D163BB-302C-4684-800D-F0F63681473CQ43727979-9B37C04F-5220-46DD-99D3-588AB86184BEQ48386560-4FE6CC6A-F340-4846-9FEA-A31DA3C6971DQ51068085-4B3D49F9-8D55-487F-982F-75DEB6A09559Q52649606-2EB8255B-C670-41F9-8083-66C4552C9DA8Q57071214-0933C264-465A-468C-980E-074E72EAF8FF
P2860
Identifying potential tumor markers and antigens by database mining and rapid expression screening
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identifying potential tumor ma ...... and rapid expression screening
@ast
Identifying potential tumor ma ...... and rapid expression screening
@en
type
label
Identifying potential tumor ma ...... and rapid expression screening
@ast
Identifying potential tumor ma ...... and rapid expression screening
@en
prefLabel
Identifying potential tumor ma ...... and rapid expression screening
@ast
Identifying potential tumor ma ...... and rapid expression screening
@en
P2093
P2860
P356
P1433
P1476
Identifying potential tumor ma ...... and rapid expression screening
@en
P2093
C J Wikstrand
G J Riggins
R L Strausberg
W T Loging
P2860
P304
P356
10.1101/GR.138000
P577
2000-09-01T00:00:00Z